ReVision Implant wins FDA breakthrough nod for vision-restoring BCI
March 9, 2026
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
A research team led by Professor Jaehyuk Cho from the Department of Software Engineering at Jeonbuk National University in South Korea, have developed an innovative model, named BiT-MAML, aimed at tackling inter-patient variability in BG prediction.
Researchers at Kiel University (CAU) have now developed a novel 3D material on which human brain cells can grow and exchange signals in the lab.
New product line extends options to better meet patient needs
LifeVac is approved for use as a single-use, non-powered, non-invasive airway clearance device.
Cedars-Sinai investigators working to optimize a cell-based treatment for retinitis pigmentosa have uncovered how transplanted neural stem cells interact with host retinal cells to preserve vision.
A new technology has been developed to suppress immune rejection, the biggest challenge in organ transplantation, without causing systemic side effects.
Researchers at Boston University Chobanian & Avedisian School of Medicine now show that it is possible to remove the caudate lobe safely using a surgical robot, even in an older patient, and still remove the cancer completely.
Philips (NYSE: PHG)+ announced today that it received FDA 510(k) clearance for its SmartHeart planning solution.
A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.